Page last updated: 2024-08-21

quinazolines and Polycystic Kidney Diseases

quinazolines has been researched along with Polycystic Kidney Diseases in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (16.67)	18.7374
1990's	1 (16.67)	18.2507
2000's	4 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Avner, ED; Frost, P; Harris, PC; Qian, Q; Sweeney, WE; Torres, VE; Wang, X	1
Furubo, S; Harada, K; Isse, K; Kizawa, K; Nakanuma, Y; Ozaki, S; Sanzen, T; Sasaki, M; Sato, Y; Yasoshima, M	1
Avner, ED; Frost, P; Futey, L; Sweeney, WE	1
Avner, ED; Chen, Y; Frost, P; Nakanishi, K; Sweeney, WE	1
Marfella-Scivittaro, C; Orellana, SA; Quiñones, A	1
Allison, ME; Dargie, HJ; Gray, MJ; Kennedy, AC	1

Trials

1 trial(s) available for quinazolines and Polycystic Kidney Diseases

Article	Year
High dosage metolazone in chronic renal failure. British medical journal, 1972, Oct-28, Volume: 4, Issue:5834 Topics: Adolescent; Adult; Aged; Animals; Creatinine; Diuretics; Female; Glomerulonephritis; Humans; Ketones; Kidney Failure, Chronic; Male; Middle Aged; Osmolar Concentration; Polycystic Kidney Diseases; Potassium; Pyelonephritis; Quinazolines; Sodium; Sulfonamides; Urination	1972

Other Studies

5 other study(ies) available for quinazolines and Polycystic Kidney Diseases

Article	Year
EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats. Kidney international, 2003, Volume: 64, Issue:5 Topics: Animals; Disease Models, Animal; ErbB Receptors; Gastric Lavage; Injections, Intraperitoneal; Male; Polycystic Kidney Diseases; Quinazolines; Rats; Rats, Sprague-Dawley	2003
Inhibition of intrahepatic bile duct dilation of the polycystic kidney rat with a novel tyrosine kinase inhibitor gefitinib. The American journal of pathology, 2006, Volume: 169, Issue:4 Topics: Animals; Bile Ducts, Intrahepatic; Dilatation, Pathologic; Disease Models, Animal; ErbB Receptors; Gefitinib; Liver; Liver Diseases; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 7; Polycystic Kidney Diseases; Protein Kinase Inhibitors; Quinazolines; Rats	2006
In vitro modulation of cyst formation by a novel tyrosine kinase inhibitor. Kidney international, 1999, Volume: 56, Issue:2 Topics: Animals; Cell Division; Cell Survival; Disease Models, Animal; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Gene Expression Regulation, Enzymologic; Kidney Tubules, Collecting; Mice; Mice, Mutant Strains; Nephrons; Organ Culture Techniques; Phosphorylation; Polycystic Kidney Diseases; Protein-Tyrosine Kinases; Quinazolines	1999
Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor. Kidney international, 2000, Volume: 57, Issue:1 Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Mice; Mice, Inbred BALB C; Polycystic Kidney Diseases; Protein-Tyrosine Kinases; Quinazolines	2000
cAMP-dependent protein kinase and proliferation differ in normal and polycystic kidney epithelia. American journal of physiology. Cell physiology, 2002, Volume: 282, Issue:4 Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Cell Division; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Epithelial Cells; ErbB Receptors; Isoquinolines; Kidney; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Phenotype; Polycystic Kidney Diseases; Quinazolines; Signal Transduction; Sulfonamides	2002